#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	9482	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2145	435.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1422	1422	C	530	C	522	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	9482	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2145	435.9	0	HET	.	.	.	C207T,G	.	207	207	C	445	445	C	523	C,T,G	387,116,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17740	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3797	463.7	0	.	n	.	0	T695C	SNP	695	695	T	1153	1153	C	547	C,T	541,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17740	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3797	463.7	0	.	n	.	0	A1638G	SNP	1638	1638	A	2096	2096	G	516	G,A	364,147	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17740	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3797	463.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2429	2429	C	569	C,T	553,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17740	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3797	463.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2503	2503	A	536	A	520	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17740	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3797	463.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3055	3055	C	541	C,T	535,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1204	folP	855	855	100.0	folP.l6.c4.ctg.1	1584	75.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1026	1028	AGC	110;113;111	A;G,T;C	108;111,1;110	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3394	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3439	98.2	1	SNP	p	S91F	1	.	.	271	273	TTC	555	557	TTC	120;119;118	T;T;C,A	115;115;112,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3394	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3439	98.2	1	SNP	p	D95G	1	.	.	283	285	GGC	567	569	GGC	108;108;107	G;G,A;C	101;102,1;100	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3394	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3439	98.2	1	SNP	p	G95N	0	.	.	283	285	GGC	567	569	GGC	108;108;107	G;G,A;C	101;102,1;100	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1008	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1273	78.4	1	SNP	p	G45D	0	.	.	133	135	GGC	455	457	GGC	129;130;133	G;G;C	129;130;131	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	552	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1017	53.9	0	.	n	.	0	A197.	DEL	197	197	A	595	595	A	118	A	118	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	114.4	1	SNP	p	D86N	0	.	.	256	258	GAC	590	592	GAC	141;141;142	G,A;A;C	135,1;133;137	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	114.4	1	SNP	p	R87W	0	.	.	259	261	CGT	593	595	CGT	141;141;144	C;G;T	138;139;140	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	114.4	1	SNP	p	R87I	0	.	.	259	261	CGT	593	595	CGT	141;141;144	C;G;T	138;139;140	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	114.4	1	SNP	p	S87R	1	.	.	259	261	CGT	593	595	CGT	141;141;144	C;G;T	138;139;140	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2948	114.4	1	SNP	p	S88P	0	.	.	262	264	TCC	596	598	TCC	144;146;144	T;C;C	136;143;141	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2604	parE	1986	1986	100.0	parE.l15.c17.ctg.1	2549	100.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1525	1527	GGC	143;141;140	G;G,C;C	141;138,1;139	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1399	1401	GCC	149;149;146	G;C;C	147;148;145	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1402	1404	ATG	148;146;148	A;T;G	148;141;147	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1414	1416	ACC	147;147;149	A;C;C	141;143;146	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1414	1416	ACC	147;147;149	A;C;C	141;143;146	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1915	1917	ACC	135;136;136	A;C;C	126;133;131	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1969	1971	GCG	121;120;120	G;C;G	121;120;118	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1969	1971	GCG	121;120;120	G;C;G	121;120;118	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2092	2094	GGT	92;92;91	G;G;T	89;89;89	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2101	2103	AGC	83;83;82	A;G;C	82;81;82	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2550	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2538	99.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2119	2121	CCG	72;73;71	C,G;C,G;G	63,1;63,1;62	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3912	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3087	125.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1649	1651	CCG	144;144;146	C,G;C,T;G,A,C	129,1;138,1;133,2,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1792	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1938	91.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	632	632	C	102	C	95	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	T89S	NONSYN	265	267	ACC	701	703	AGC	148;146;147	A;G;C	143;143;147	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	.	MULTIPLE	358	359	AA	793	794	CG	125;121	C;G	120;117	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	.	MULTIPLE	361	362	GA	796	798	CAG	123;124;123	C;A;G	119;120;118	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	N122K	NONSYN	364	366	AAC	800	802	AAA	121;120;124	A;A;A	114;116;120	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	827	829	TAT	130;130;132	T;A;T	127;129;128	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	N134E	NONSYN	400	402	AAT	836	838	GAG	134;133;134	G;A;G	134;131;133	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	V135F	NONSYN	403	405	GTG	839	841	TTT	131;132;133	T,G;T;T	120,2;129;131	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	G140K	NONSYN	418	420	GGA	854	856	AAA	139;143;142	A;A;A	135;141;139	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	K143E	NONSYN	427	429	AAA	863	865	GAA	146;146;147	G;A;A	140;142;141	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	V151A	NONSYN	451	453	GTA	887	889	GCA	155;154;155	G;C;A,C	153;153;149,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	Y212R	NONSYN	634	636	TAT	1070	1072	CGT	147;149;149	C,T;G,A;T,G	136,1;143,1;136,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	T213L	NONSYN	637	639	ACA	1073	1075	TTA	149;152;152	T,A;T,C;A	146,1;147,1;142	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	.	MULTIPLE	760	761	AC	1196	1198	GCA	161;160;158	G;C;A	159;154;157	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	0	.	p	.	0	W255fs	FSHIFT	763	763	T	1200	1200	T	160	T,G	158,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	1	SNP	p	G120K	1	.	.	358	360	AAG	793	795	CGG	125;121;121	C;G;G,C	120;117;117,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	1	SNP	p	A121D	1	.	.	361	363	GAC	796	799	CGC	123;123;125	C;G;C	119;118;119	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	1860	porB1b	1041	1041	97.32	porB1b.l6.c4.ctg.1	1774	103.9	1	SNP	p	D121N	0	.	.	361	363	GAC	796	799	CGC	123;123;125	C;G;C	119;118;119	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6590	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4984	131.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	764	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1086	69.2	1	SNP	p	V57M	1	.	.	169	171	ATG	510	512	ATG	139;140;143	A;T;G	137;139;139	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
